LENZ THERAPEUTICS, INC. (LENZ) Free cash flow 2020–2025
LENZ THERAPEUTICS, INC. (LENZ) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$70.0MFY2025 · since FY2020: -$10.3M → -$70.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$70.0M | -16.9% |
| FY2024 | -$59.9M | +0.9% |
| FY2023 | -$60.4M | +36.1% |
| FY2022 | -$94.6M | -61.4% |
| FY2021 | -$58.6M | -470.7% |
| FY2020 | -$10.3M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice